MAP4K1 and neoplasm: Recent studies demonstrated that inhibition of HPK1 kinase function by knockout of HPK1, knockin of kinase-dead mutant M46, or inhibition of HPK1 kinase activity using small-molecular inhibitors enhances the antitumor T cell functions and inhibition of tumor growth in synergistic allograft mouse models (19–23).